Patents by Inventor Johannes Martinus Maria Bloemers

Johannes Martinus Maria Bloemers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF TESTOSTERONE AND A 5-HT1A AGONIST IN THE TREATMENT OF SEXUAL DYSFUNCTION
    Publication number: 20140038929
    Abstract: The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of testosterone and a 5-HT1A agonist.
    Type: Application
    Filed: October 8, 2013
    Publication date: February 6, 2014
    Applicant: EMOTIONAL BRAIN B.V.
    Inventors: Jan Johan Adriaan TUITEN, Johannes Martinus Maria BLOEMERS, Robertus Petrus Johannes DE LANGE
  • Use of testosterone and a 5-HT1a agonist in the treatment of sexual dysfunction
    Patent number: 8575139
    Abstract: The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of testosterone and a 5-HT1A agonist.
    Type: Grant
    Filed: November 2, 2007
    Date of Patent: November 5, 2013
    Assignee: Emotional Brain B.V.
    Inventors: Jan Johan Adriaan Tuiten, Johannes Martinus Maria Bloemers, Robertus Petrus Johannes De Lange
  • USE OF TESTOSTERONE AND A 5-HT1A AGONIST IN THE TREATMENT OF SEXUAL DYSFUNCTION
    Publication number: 20120277200
    Abstract: The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of testosterone and a 5-HT1A agonist.
    Type: Application
    Filed: July 10, 2012
    Publication date: November 1, 2012
    Inventors: Jan Johan Adriaan TUITEN, Johannes Martinus Maria BLOEMERS, Robertus Petrus Johannes DE LANGE
  • USE OF TESTOSTERONE AND A 5-HT1A AGONIST IN THE TREATMENT OF SEXUAL DYSFUNCTION
    Publication number: 20100160270
    Abstract: The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of testosterone and a 5-HT1A agonist.
    Type: Application
    Filed: November 2, 2007
    Publication date: June 24, 2010
    Inventors: Jan Johan Adriaan Tuiten, Johannes Martinus Maria Bloemers, Robertus Petrus Johannes De Lange
  • USE OF 3-ALPHA-ANDROSTANEDIOL, OPTIONALLY IN COMBINATION WITH A PDE5 INHIBITOR, IN THE TREATMENT OF SEXUAL DYSFUNCTION
    Publication number: 20100152145
    Abstract: The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of 3-alpha-androstanediol, preferably in combination with a type 5 phosphodiesterase (PDE5) inhibitor.
    Type: Application
    Filed: November 2, 2007
    Publication date: June 17, 2010
    Inventors: Jan Johan Adriaan Tuiten, Johannes Martinus Maria Bloemers, Robertus Petrus Johannes De Lange
  • USE OF 3-ALPHA-ANDROSTANEDIOL, OPTIONALLY IN COMBINATION WITH A 5-HT1A AGONIST, IN THE TREATMENT OF SEXUAL DYSFUNCTION
    Publication number: 20100093680
    Abstract: The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of 3-alpha-androstanediol, preferably in combination with a 5-HT1A agonist. Optionally, said 3-alpha-androstanediol and said 5HT1a agonist are further combined with a type 5 phosphodiesterase (PDE5) inhibitor.
    Type: Application
    Filed: November 2, 2007
    Publication date: April 15, 2010
    Inventors: Jan Johan Adriaan Tuiten, Johannes Martinus Maria Bloemers, Robertus Petrus Johannes De Lange